New drug KBP-5074 tested for safety in small Early-Stage trial
NCT ID NCT02653014
First seen Dec 26, 2025 · Last updated May 23, 2026 · Updated 24 times
Summary
This early-stage study tested the safety and how the body processes KBP-5074 in 26 healthy adults and people with mild to moderate kidney impairment. Researchers measured side effects and drug levels in the blood to help design future larger studies. No treatment was given; the goal was only to gather safety and dosing information.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Research by Design, LLC
Evergreen Park, Illinois, 60805, United States
Conditions
Explore the condition pages connected to this study.